Nausicaa Malissen
Aix-Marseille Université(FR)Centre de Recherche en Cancérologie de Marseille(FR)
Publications by Year
Research Areas
Cancer Immunotherapy and Biomarkers, Melanoma and MAPK Pathways, Immunotherapy and Immune Responses, CAR-T cell therapy research, Cutaneous Melanoma Detection and Management
Most-Cited Works
- → Clinical Features, Management, and Outcomes of Immune Checkpoint Inhibitor–Related Cardiotoxicity(2017)502 cited
- → Intratumoral dendritic cell–CD4+ T helper cell niches enable CD8+ T cell differentiation following PD-1 blockade in hepatocellular carcinoma(2023)367 cited
- → Single-cell analysis of human non-small cell lung cancer lesions refines tumor classification and patient stratification(2021)335 cited
- → Loss of H3K27 trimethylation is not suitable for distinguishing malignant peripheral nerve sheath tumor from melanoma: a study of 387 cases including mimicking lesions(2017)88 cited
- → Survival of melanoma patients treated with targeted therapy and immunotherapy after systematic upfront control of brain metastases by radiosurgery(2017)80 cited
- → HVEM has a broader expression than PD-L1 and constitutes a negative prognostic marker and potential treatment target for melanoma(2019)55 cited
- → Long-term treatment of cutaneous manifestations of tuberous sclerosis complex with topical 1% sirolimus cream: A prospective study of 25 patients(2017)53 cited
- → Macrophage activation syndrome: A new complication of checkpoint inhibitors(2017)45 cited
- → Metastatic Melanoma: Recent Therapeutic Progress and Future Perspectives(2018)44 cited
- → Diabetes and Blood Glucose Disorders Under Anti-PD1(2018)37 cited